Comparing the effectiveness and safety of Sorafenib plus TACE with Apatinib plus TACE for treating patients with unresectable hepatocellular carcinoma: a multicentre propensity score matching study

Yin, Liang; Liu, Kai-Cai; Lv, Wei-Fu; Lu, Dong; Tan, Yu-Lin; Wang, Guo-Xiang; Dai, Jia-Ying; Zhu, Xian-Hai; Jiang, Bo

doi:10.1186/s40644-023-00574-7

Cancer Imaging

Article metrics
Last updated: Tue, 30 Apr 2024 1:35:35 Z

Comparing the effectiveness and safety of Sorafenib plus TACE with Apatinib plus TACE for treating patients with unresectable hepatocellular carcinoma: a multicentre propensity score matching study

Access & Citations

1408

Article Accesses
0

Web of Science
4

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1470-7330

Contact us

Submission enquiries: alyzza.javate@springernature.com
General enquiries: info@biomedcentral.com